Skip to Main Content

Paper Details

Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo.
J Clin Invest
17
2022
Author NameAffiliation
Rab K PrinjhaImmunology Research Unit, GSK Medicines Research Centre
Ronald SwanstromUniversity of North Carolina (UNC)
Ronald SwanstromUNC School of Medicine
Edward P BrowneUniversity of North Carolina (UNC)
Edward P BrowneUNC School of Medicine
Edward P Browne
Brian D StrahlUniversity of North Carolina (UNC)
Brian D StrahlUNC School of Medicine
  • 1 - 8

Datasets

Release 1.2